Compare · EKSO vs LRCX
EKSO vs LRCX
Side-by-side comparison of Ekso Bionics Holdings Inc. (EKSO) and Lam Research Corporation (LRCX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EKSO operates in Industrials, while LRCX operates in Technology - the two are in different parts of the market.
- LRCX is the larger of the two at $391.80B, about 9318.0x EKSO ($42.0M).
- Over the past year, EKSO is up 183.5% and LRCX is up 207.9% - LRCX leads by 24.4 points.
- EKSO has been more active in the news (10 items in the past 4 weeks vs 5 for LRCX).
- LRCX has more recent analyst coverage (25 ratings vs 0 for EKSO).
- Company
- Ekso Bionics Holdings Inc.
- Lam Research Corporation
- Price
- $11.37-1.52%
- $313.12-2.44%
- Market cap
- $42.0M
- $391.80B
- 1M return
- +22.26%
- -15.23%
- 1Y return
- +183.54%
- +207.90%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1984
- News (4w)
- 10
- 5
- Recent ratings
- 0
- 25
Ekso Bionics Holdings Inc.
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Latest EKSO
- SEC Form EFFECT filed by Ekso Bionics Holdings Inc.
- Chief Executive Officer Chen Ying Cenly was granted 2,800,000 shares (SEC Form 4)
- Amendment: SEC Form S-3/A filed by Ekso Bionics Holdings Inc.
- SEC Form S-8 filed by Ekso Bionics Holdings Inc.
- SEC Form 8-K12B filed by Ekso Bionics Holdings Inc.
- SEC Form S-3 filed by Ekso Bionics Holdings Inc.
- Director Schaap Andrew Cordell was granted 200,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Schaap Andrew Cordell
- Amendment: Ekso Bionics Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Other Events
- Ekso Bionics Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
Latest LRCX
- The Hidden Layer of the AI Boom: Robotics, Packaging Equipment Companies Are Thriving
- Director Talwalkar Abhijit Y sold $6,124,470 worth of shares (18,282 units at $335.00) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 87,142 units (SEC Form 4)
- Lam Research Corporation Announces June Quarter Financial Conference Call
- President and CEO Archer Timothy exercised 30,000 shares at a strike of $30.03 and sold $11,700,300 worth of shares (30,000 units at $390.01) as part of a pre-agreed trading plan (SEC Form 4)
- Taiwan Semiconductor Suppliers Are Moving to the US, Creating New Opportunities
- SEC Form 11-K filed by Lam Research Corporation
- Director Brandt Eric sold $20,011,346 worth of shares (54,500 units at $367.18) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 144,705 units (SEC Form 4)
- Director Brandt Eric sold $19,118,360 worth of shares (54,500 units at $350.80) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 199,205 units (SEC Form 4)
- Senior Vice President Fernandes Neil J sold $2,371,226 worth of shares (7,659 units at $309.60) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 58,470 units (SEC Form 4)
- SEC Form SD filed by Lam Research Corporation